cubeCONSENT 3.0 - For Subjects
ASO Keyword Dashboard
Tracking 3 keywords for cubeCONSENT 3.0 - For Subjects in Apple App Store
cubeCONSENT 3.0 - For Subjects tracks 3 keywords (3 keywords rank; full coverage across the tracked set). Key metrics: 0% top-10 coverage, opportunity 71.3, difficulty 38.5, best rank 12.
Tracked keywords
3
3 ranked • 0 not ranking yet
Top 10 coverage
0%
Best rank 12 • Latest leader 32
Avg opportunity
71.3
Top keyword: subject
Avg difficulty
38.5
Lower scores indicate easier wins
Opportunity leaders
- 64.4
subject
Opportunity: 73.0 • Difficulty: 45.0 • Rank 32
Competitors: 234
- 56.3
subjects
Opportunity: 71.0 • Difficulty: 34.6 • Rank 12
Competitors: 18
- 50.7
consent
Opportunity: 70.0 • Difficulty: 35.8 • Rank 19
Competitors: 30
Unranked opportunities
Every tracked keyword currently has some ranking data.
High competition keywords
subject
Total apps: 7,050 • Major competitors: 234
Latest rank: 32 • Difficulty: 45.0
subjects
Total apps: 2,329 • Major competitors: 18
Latest rank: 12 • Difficulty: 34.6
consent
Total apps: 1,076 • Major competitors: 30
Latest rank: 19 • Difficulty: 35.8
All tracked keywords
Includes opportunity, difficulty, rankings and competitor benchmarks
| Major Competitors | |||||||
|---|---|---|---|---|---|---|---|
| subjects | 71 | 100 | 35 | 56 2,329 competing apps Median installs: 450 Avg rating: 4.2 | 12 | 12 | 18 major competitor apps |
| consent | 70 | 100 | 36 | 51 1,076 competing apps Median installs: 1,100 Avg rating: 4.0 | 19 | 17 | 30 major competitor apps |
| subject | 73 | 100 | 45 | 64 7,050 competing apps Median installs: 650 Avg rating: 4.1 | 32 | 19 | 234 major competitor apps |
App Description
App Features:
- Easy mobile phone access to clinical trial consent forms.
- Quick and secure eSignatures.
- Unlimited downloads of signed consent forms.
CRScube:
CRScube provides a comprehensive suite of eClinical solutions to CROs, Biotech, Pharmaceutical, Academic, and Non-Profit organizations globally. We are dedicated to providing the latest eClinical technology that is fast, flexible, and easy-to-use to streamline end-to-end operations for Phase I-IV, medical device, and Investigator-Initiated Trials.